DI LEO, Alfredo
 Distribuzione geografica
Continente #
NA - Nord America 16.136
EU - Europa 2.728
AS - Asia 1.254
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
AF - Africa 1
SA - Sud America 1
Totale 20.133
Nazione #
US - Stati Uniti d'America 16.116
CN - Cina 1.064
SE - Svezia 854
DE - Germania 451
IT - Italia 363
UA - Ucraina 330
FI - Finlandia 220
GB - Regno Unito 202
BE - Belgio 93
FR - Francia 67
VN - Vietnam 57
SG - Singapore 40
IE - Irlanda 36
IN - India 36
RU - Federazione Russa 27
CZ - Repubblica Ceca 21
RO - Romania 20
IR - Iran 17
CA - Canada 9
GT - Guatemala 9
NL - Olanda 9
ES - Italia 8
JP - Giappone 8
KR - Corea 7
AU - Australia 6
EU - Europa 6
PH - Filippine 5
CH - Svizzera 4
MK - Macedonia 4
AL - Albania 3
BG - Bulgaria 3
LU - Lussemburgo 3
TR - Turchia 3
HK - Hong Kong 2
HU - Ungheria 2
ID - Indonesia 2
IL - Israele 2
KZ - Kazakistan 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
IM - Isola di Man 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MY - Malesia 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
ZA - Sudafrica 1
Totale 20.133
Città #
Fairfield 2.601
Woodbridge 1.917
Chandler 1.399
Houston 1.266
Ashburn 1.121
Seattle 1.055
Cambridge 904
Ann Arbor 865
Jacksonville 824
Wilmington 819
Nyköping 713
Lawrence 294
Roxbury 286
Nanjing 253
New York 244
Beijing 234
Des Moines 174
Bari 172
Dearborn 154
Inglewood 138
Princeton 126
Boardman 101
Brussels 93
San Diego 87
Brooklyn 67
Nanchang 67
Shenyang 65
Hebei 58
Dong Ket 55
Jiaxing 53
Tianjin 40
Changsha 39
Dublin 36
Paris 35
Los Angeles 34
Hefei 31
London 31
Singapore 29
Pune 26
Redwood City 26
Falls Church 25
Guangzhou 21
Augusta 19
Brno 19
Zhengzhou 18
Jinan 17
Kunming 17
Shanghai 16
Ardabil 15
Helsinki 15
Norwalk 15
San Mateo 15
Hangzhou 14
Washington 14
Leawood 13
Milan 12
Munich 12
Edinburgh 10
Indiana 10
Chicago 9
Guatemala City 9
Hounslow 9
Ostuni 9
Rome 9
Toronto 9
Prescot 8
Tappahannock 8
Wuhan 8
Auburn Hills 7
Kilburn 7
Redmond 6
Tokyo 6
Triggiano 6
Cutrofiano 5
Mountain View 5
Ningbo 5
Orihuela Costa 5
Taizhou 5
Esslingen am Neckar 4
Frankfurt am Main 4
Jinhua 4
Monmouth Junction 4
Mumbai 4
Nanning 4
Nürnberg 4
San Francisco 4
San Jose 4
Shenzhen 4
Taranto 4
Acton 3
Bitetto 3
Böblingen 3
Grafing 3
Madrid 3
Melbourne 3
Southwark 3
Sterling 3
Tetovo 3
Varese 3
Xian 3
Totale 17.041
Nome #
Obesity as predictor of postoperative outcomes in liver transplant candidates: Review of the literature and future perspectives 139
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 136
Assessment of Disease Activity in Small Bowel Crohn’s Disease: Comparison between Endoscopy and Magnetic Resonance Enterography Using MRIA and Modified MRIA Score 134
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 130
Endothelial dysfunction correlates with liver fibrosis in chronic HCV infection 127
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 126
Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis 122
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 122
Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity. 121
A comparison of the nutritional status between adult celiac patients on a long-term, strictly gluten-free diet and healthy subjects 120
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 119
Role of Bone Marrow-Derived Stem Cells in Polyps Development in Mice with Apc(Min/+) Mutation 119
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 119
Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation 115
Virus C hepatitis and type 2 diabetes: a cohort study in southern Italy. 112
Polyamine biosynthesis in relation to K-ras and p-53 mutations in colorectal carcinoma 112
Estrogen-induced proliferation in cultured hepatocytes involves cyclin D1, p21(Cip1) and p27(Kip1) 111
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients 111
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study 109
Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy 108
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. 108
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 108
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy 108
Serum fructosamine and colorectal adenomas 107
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 107
White Paper of Italian Gastroenterology: Delivery of services for digestive diseases in Italy: Weaknesses and strengths 106
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 106
Anti-viral therapy in chronic HBV infection: a single centre experience. 105
Gut Microbiota Imbalance is Related to Sporadic Colorectal Neoplasms. A Pilot Study 105
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 105
Antiviral activity and safety profile of silibinin in HCV patients with advanced fibrosis after liver transplantation: a randomized clinical trial 103
Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up 103
Phytoestrogens: Dietary Intake, Bioavailability, and Protective Mechanisms against Colorectal Neoproliferative Lesions 103
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 103
Endothelial function and cardiovascular risk in active inflammatory bowel diseases. 102
Olive oil and omega-3 polyunsaturated fatty acids suppress intestinal polyp growth by modulating the apoptotic process in ApcMin/+ mice 102
The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine. 101
null 101
null 100
Disseminated tumour cells in bone marrow in experimental colon cancer: metastatic or resident? 99
null 99
H. pylori status and angiogenesis factors in human gastric carcinoma 98
Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. 98
MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma 97
Genetic and biochemical changes in colorectal carcinoma in relation to morphologic characteristics 96
Dietary Lifestyle and Colorectal Cancer Onset, Recurrence, and Survival: Myth or Reality? 95
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 95
What Is the Optimal Follow-up Time to Ascertain the Safety of Proton Pump Inhibitors? 95
A mysterious case of gastroparesis: could the secret be found in a drink? 94
null 93
Can the Antisecretory Factor Be Considered a New Therapy for the Short Bowel Syndrome? 93
Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C. 91
Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection 91
Estrogens, phytoestrogens and colorectal neoproliferative lesions 91
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 91
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 90
Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence 90
null 89
Circadian rhythm of hepatic cytosolic and nuclear estrogen and androgen receptors. 88
Higher farnesyl diphosphate synthase activity in human colorectal cancer: inhibition of cellular apoptosis 88
null 88
Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liver. 87
Phytoestrogens/insoluble fibers and colonic estrogen receptor β: Randomized, double-blind, placebo-controlled study 87
HBsAg clearance by Peg-interferon addition to a long-term nucleos(t)ide analogue therapy. 86
Liver stiffness and portal blood flow modifications induced by a liquid meal consumption: Pathogenetic mechanisms and clinical relevance 86
null 86
Sex steroid hormone receptors and human gallbladder motility in vitro. 85
In vitro gallbladder motility in patients with radiolucent and radiopaque stones. 85
Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients 85
Sliding gastric hiatal hernia diagnosis by transabdominal ultrasonography: an easy, reliable and non-invasive procedure 85
Altered molecular pattern of mucosal healing in Crohn's disease fibrotic stenosis 85
Functional modification of CD11c+ liver dendritic cells during liver regeneration after partial hepatectomy in mice 85
Bone marrow-derived stem cells and hepatocarcinogenesis in hepatitis B virus transgenic mice 84
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 84
null 83
null 83
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori 83
Helicobacter pylori is associated with modified lipid profile: impact on Lipoprotein(a) 82
ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption 82
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? 82
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 82
Estrogens and colorectal cancer. 81
Tumor necrosis factor alpha and apoptosis in Helicobacter pylori related progressive gastric damage: a possible mechanism of immune system involvement in epithelial turnover regulation 81
null 81
null 81
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement 81
Survival after the diagnosis of de novo malignancy in liver transplant recipients 81
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 81
null 80
Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients 80
Antagonistic activity of potential probiotic Lactobacilli against the ureolytic pathogen Yersinia enterocolitica 80
null 80
Sex steroid hormone receptors, epidermal growth factor receptor, and polyamines in human colorectal cancer. 79
null 79
Relationship among red blood cell polyamine content, phagocytic activities and plasma endotoxins in untreated colorectal cancer patients 79
null 79
null 79
null 79
Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma 79
Estrogen receptor β controls proliferation of enteric glia and differentiation of neurons in the myenteric plexus after damage 78
Totale 9.649
Categoria #
all - tutte 81.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.302 818 285 255 593 658 494 678 659 784 394 468 216
2020/20213.758 298 320 266 283 365 191 385 412 244 485 258 251
2021/20222.128 128 188 55 99 111 178 82 132 142 157 350 506
2022/20233.527 493 435 246 291 385 497 37 406 558 21 97 61
2023/20241.236 105 233 52 115 94 352 29 44 8 57 15 132
2024/202580 80 0 0 0 0 0 0 0 0 0 0 0
Totale 21.020